Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.
Janssen QP, van Dam JL, Prakash LR, Doppenberg D, Crane CH, van Eijck CHJ, Ellsworth SG, Jarnagin WR, O'Reilly EM, Paniccia A, Reyngold M, Besselink MG, Katz MHG, Tzeng CD, Zureikat AH, Groot Koerkamp B, Wei AC; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Janssen QP, et al. Among authors: katz mhg. J Natl Compr Canc Netw. 2022 Jul;20(7):783-791.e1. doi: 10.6004/jnccn.2022.7008. J Natl Compr Canc Netw. 2022. PMID: 35830887 Free PMC article.
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation.
Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Katz MH, et al. Ann Surg Oncol. 2010 Jul;17(7):1794-801. doi: 10.1245/s10434-010-0943-1. Epub 2010 Feb 17. Ann Surg Oncol. 2010. PMID: 20162463 Free PMC article.
Current status of adjuvant therapy for pancreatic cancer.
Katz MH, Fleming JB, Lee JE, Pisters PW. Katz MH, et al. Oncologist. 2010;15(11):1205-13. doi: 10.1634/theoncologist.2010-0121. Epub 2010 Nov 2. Oncologist. 2010. PMID: 21045189 Free PMC article.
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.
Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Chatterjee D, et al. Cancer. 2012 Jun 15;118(12):3182-90. doi: 10.1002/cncr.26651. Epub 2011 Oct 25. Cancer. 2012. PMID: 22028089 Free PMC article.
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R, Balachandran A, Varadhachary GR, Pisters PW, Wang H, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Zhao Q, et al. Ann Diagn Pathol. 2012 Jan;16(1):29-37. doi: 10.1016/j.anndiagpath.2011.08.005. Epub 2011 Nov 3. Ann Diagn Pathol. 2012. PMID: 22050964 Free PMC article.
Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.
Katz MH, Wang H, Balachandran A, Bhosale P, Crane CH, Wang X, Pisters PW, Lee JE, Vauthey JN, Abdalla EK, Wolff R, Abbruzzese J, Varadhachary G, Chopin-Laly X, Charnsangavej C, Fleming JB. Katz MH, et al. J Gastrointest Surg. 2012 Jan;16(1):68-78; discussion 78-9. doi: 10.1007/s11605-011-1748-7. Epub 2011 Nov 8. J Gastrointest Surg. 2012. PMID: 22065318
384 results